EV Biologics, Inc. (YECO)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 10:09AM EDT
| Previous Close | 0.6221 |
| Open | 0.6221 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.6221 - 0.6221 |
| 52 Week Range | 0.5630 - 1.9500 |
| Volume | |
| Avg. Volume | 232 |
| Market Cap | 6.361M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2800 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 32.00 |
ACCESSWIREEV Biologics Updates on Funding and Sales
TAMPA, FL / ACCESSWIRE / October 2, 2023 / EV Biologics Corp, (OTC Pink:YECO), today announced that it has closed a $500,000 interest-free loan from a related party.This funding will provide for further development of exosome - and other nanoparticle-enriched ...
- ACCESSWIRE
EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic
EV Biologics Corp, OTC PINK:YECO, today announced that it has completed production of a next-generation, "Gen-2", MSC exosome-based therapeutic product.
- ACCESSWIRE
EV Biologics Appoints Senior Investment Banker as Corporate Finance Director
EV Biologics Corp, OTC PINK:YECO, today announced that it has appointed William Bossung as Corporate Finance Director.
© 2024 Yahoo. All rights reserved.